iShares SMI ETF (CH) holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
iShares SMI® ETF (CH) CSSMI
Morningstar’s Analysis CSSMI
Will CSSMI outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 83.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Roche Holding AG Ordinary Shares new | 18.23 | 494M | Healthcare |
Novartis AG Registered Shares | 16.44 | 446M | Healthcare |
Nestle SA | 14.03 | 380M | Consumer Defensive |
UBS Group AG Registered Shares | 7.74 | 210M | Financial Services |
ABB Ltd | 7.08 | 192M | Industrials |
Zurich Insurance Group AG | 6.09 | 165M | Financial Services |
Compagnie Financiere Richemont SA Class A | 5.73 | 155M | Consumer Cyclical |
Lonza Group Ltd | 2.91 | 79M | Healthcare |
Swiss Re AG | 2.90 | 79M | Financial Services |
Holcim Ltd | 2.37 | 64M | Basic Materials |